Prior studies have revealed that in Alzheimer’s disease, TREM2-deficient microglia present impaired activation of the mTOR signaling pathway, resulting in decreased ATP levels and obstructed biosynthetic pathways that in turn, trigger an abnormal increase in microglial autophagy. Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.